MeSH term
Frequency | Condition_Probility | Animals | 42 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Male | 13 | 0.0 |
Mice | 14 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 35 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
*mRNA Cleavage and Polyadenylation Factors | 2 | 15.0 |
Clostridium Infections/*microbiology | 2 | 100.0 |
Food Poisoning/*microbiology | 3 | 75.0 |
Gene Expression Regulation, Bacterial | 3 | 5.0 |
Genes, Bacterial | 3 | 2.0 |
Humans | 72 | 0.0 |
Molecular Weight | 6 | 0.0 |
Base Sequence | 16 | 0.0 |
Comparative Study | 13 | 0.0 |
Exons/genetics | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Molecular Sequence Data | 28 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Amino Acid Sequence | 21 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 30 | 0.0 |
*Xenopus Proteins | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
Enterotoxins/metabolism/*toxicity | 2 | 100.0 |
Carboxypeptidase H | 23 | 85.0 |
Carboxypeptidases/*metabolism | 3 | 20.0 |
Proprotein Convertases | 5 | 10.0 |
Protein Precursors/*metabolism | 2 | 2.0 |
Rats | 13 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Caco-2 Cells | 3 | 0.0 |
*Calcium-Binding Proteins | 3 | 6.0 |
Clostridium perfringens/*pathogenicity | 3 | 75.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Cell Line | 12 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Enzyme Stability | 2 | 1.0 |
Female | 13 | 0.0 |
Genetic Screening | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Kinetics | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
Adult | 7 | 0.0 |
Aged | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Middle Aged | 5 | 0.0 |
Protein Processing, Post-Translational | 4 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 2 | 0.0 |
Genotype | 2 | 0.0 |
Plasmids/genetics | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Sequence Analysis, DNA | 7 | 0.0 |
Spores, Bacterial/genetics/physiology | 2 | 100.0 |
Transcription, Genetic | 5 | 0.0 |
Cytopathogenic Effect, Viral | 7 | 4.0 |
Blotting, Western | 6 | 0.0 |
Chromosomes, Bacterial | 2 | 5.0 |
Food Poisoning/microbiology | 2 | 28.0 |
*Heat | 2 | 1.0 |
Clostridium perfringens | 2 | 100.0 |
Rabbits | 3 | 0.0 |
Transfection | 6 | 0.0 |
Cell Membrane/enzymology | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Secretory Vesicles/metabolism | 2 | 20.0 |
Biological Transport | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
*Repressor Proteins | 3 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Clostridium perfringens/genetics/*pathogenicity | 2 | 100.0 |
Enterotoxins/*genetics | 2 | 28.0 |
Mutation | 4 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Species Specificity | 4 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Carboxypeptidases/*genetics | 5 | 22.0 |
Gene Expression | 2 | 0.0 |
Genes, Structural/*genetics | 2 | 0.0 |
Cloning, Molecular | 10 | 0.0 |
Furin | 4 | 8.0 |
*Multienzyme Complexes | 2 | 2.0 |
Centrifugation | 3 | 4.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Cattle | 3 | 0.0 |
*Proteins | 2 | 0.0 |
Japan/epidemiology | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Microscopy, Electron | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Organ Specificity | 4 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Carboxypeptidases/metabolism | 3 | 15.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Protein Precursors/metabolism | 2 | 1.0 |
Proinsulin/chemistry/genetics/metabolism | 2 | 100.0 |
Subtilisins/metabolism | 2 | 13.0 |
Protein Conformation | 3 | 0.0 |
Carboxypeptidases/biosynthesis/*genetics | 3 | 75.0 |
Food Microbiology | 2 | 6.0 |
Infant, Newborn | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Proprotein Convertase 2 | 4 | 20.0 |
Sudden Infant Death/*etiology | 2 | 25.0 |
Heat | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
*Clostridium perfringens | 2 | 100.0 |
Enterotoxins/*analysis | 2 | 28.0 |
*Disease Outbreaks | 2 | 3.0 |
Plasmids | 2 | 0.0 |
Nerve Tissue Proteins/metabolism | 2 | 0.0 |
Neuropeptides/metabolism | 2 | 3.0 |
